Cited by 81Regulation of Appetite and ObesityNeuroendocrine regulation and behaviorHypothalamic control of reproductive hormones

Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas

Maejima, Yuko, Rita, Rauza Sukma, Santoso, Putra, Aoyama, Masato, Hiraoka, Yuichi, Nishimori, Katsuhiko, Gantulga, Darambazar, Shimomura, Kenju +1 more·2015·Neuroendocrinology

Abstract

Recent studies have considered oxytocin (Oxt) as a possible medicine to treat obesity and hyperphagia. To find the effective and safe route for Oxt treatment, we compared the effects of its nasal and intraperitoneal (IP) administration on food intake, locomotor activity, and glucose tolerance in mice. Nasal Oxt administration decreased food intake without altering locomotor activity and increased the number of c-Fos-immunoreactive (ir) neurons in the paraventricular nucleus (PVN) of the hypothalamus, the area postrema (AP), and the dorsal motor nucleus of vagus (DMNV) of the medulla. IP Oxt administration decreased food intake and locomotor activity and increased the number of c-Fos-ir neurons not only in the PVN, AP, and DMNV but also in the nucleus of solitary tract of the medulla and in the arcuate nucleus of the hypothalamus. In IP glucose tolerance tests, IP Oxt injection attenuated the rise of blood glucose, whereas neither nasal nor intracerebroventricular Oxt affected blood glucose. In isolated islets, Oxt administration potentiated glucose-induced insulin secretion. These results indicate that both nasal and IP Oxt injections reduce food intake to a similar extent and increase the number of c-Fos-ir neurons in common brain regions. IP Oxt administration, in addition, activates broader brain regions, reduces locomotor activity, and affects glucose tolerance possibly by promoting insulin secretion from pancreatic islets. In comparison with IP administration, the nasal route of Oxt administration could exert a similar anorexigenic effect with a lesser effect on peripheral organs.

Integrity signals

Registry

Crossref · 10.1159/000371636

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Maejima et al. reported that 10 μg intranasal oxytocin activated Fos expression in the paraventricular nucleus, area postrema, and dorsal motor nucleus of the vagus; the area postrema lies outside the blood-brain barrier and should not be reachable from CSF, and the same areas were activated by systemic oxytocin.

    “Maejima et al. reported that intranasal administration of a higher dose of oxytocin (10µg) activated Fos expression at the paraventricular nucleus, the area postrema and the dorsal motor nucleus of the vagus (29).The area postrema is outside the blood-brain barrier, and should not be accessible to oxytocin from the CSF.These same areas were also activated by oxytocin given systemically.”

    From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [29]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maejima, Y., Rita, R. S., Santoso, P., Aoyama, M., Hiraoka, Y., Nishimori, K., Gantulga, D., Shimomura, K., & Yada, T.
Affiliations
  • Jichi Medical University (JP)
  • Utsunomiya University (JP)
  • Tohoku University (JP)
Venue
Neuroendocrinology
Publisher
S. Karger AG
Published
2015
Volume
101
Issue
1
Pages
35-44
ISSN
  • 0028-3835 (ISSN-L)
  • 1423-0194
OpenAlex
W1997601041
Cited by
81
References
50
Citations by year
2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 9 · 2018: 12 · 2017: 6 · 2016: 10 · 2015: 4
FWCI
5.91
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (15H02442, 26461366, 15K09395, 24591341)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
oxytocin, intranasal administration, intraperitoneal administration, dietary intake, hyperphagia, obesity, locomotor activity, glucose tolerance, glycemia, c-fos, paraventricular nucleus, area postrema, dorsal motor nucleus of the vagus, solitary tract nucleus, arcuate nucleus, insulin secretion, pancreatic islets, anorectic effect
MeSH terms
Administration, Intranasal, Animals, Blood Glucose, Brain, Eating, Glucose Tolerance Test, Male, Mice, Inbred C57BL, Motor Activity, Neurons, Oxytocin, Proto-Oncogene Proteins c-jun, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review